Factors associated with a reduction in glomerular filtration rate in patients with chronic obstructive pulmonary disease


Cite item

Full Text

Abstract

Aim. Analysis of factors associated with reduced glomerular filtration rate (GFR) in patients with chronic obstructive pulmonary disease (COPD). Materials and methods. The study included 198 patients with COPD 1-4 degrees of severity (GOLD 2014), who were on examination and treatment in Krasnodar Regional clinical hospital № 2. The control group consisted of 28 healthy volunteers, comparable in age and sex. In addition to clinical research, all patients, we calculated GFR according to the formula CKD-EPI based on cystatin C serum (GFRcys). The contribution of the factors in the risk of developing CKD was determined using multivariate linear regression analysis, as dependent variable used the value of GFRcys. Results and discussion. It was found that more than half (51.5%) of patients with COPD have a decrease in GFRcys <60 ml/min/1.73 m2, which is the basis for the diagnosis of CKD without laboratory and instrumental studies. During the regression analysis with direct step - by - step inclusion of the selected variables, the independent factors associated with a decrease in GFR in COPD patients were determined: the value of FEV1, SpO2, the number of points on the mMRC scale, the level of C-reactive protein, fibrinogen, and the smoker index. The high incidence of CKD in patients with COPD (51.5%), as well as the correlation between the presence of renal dysfunction and the severity of COPD were revealed. The influence of clinical and diagnostic parameters of COPD severity on the development of renal dysfunction was confirmed.

About the authors

E. V Bolotova

Kuban State Medical University

д.м.н., проф. каф. терапии №1 факультета повышения квалификации и профессиональной переподготовки специалистов; ORCID: 0000-0001-6257-354X Krasnodar, Russia

A. V Dudnikova

Kuban State Medical University

Email: avdudnikova@yandex.ru
к.м.н. врач-терапевт, клиника ФГБОУ ВО «КубГМУ»; тел.: +7(918)673-32-23; ORCID: 0000-0003-2601-7831 Krasnodar, Russia

References

  1. Клинические практические рекомендации KDIGO 2012 по диагностике и лечению хронической болезни почек. Нефрология и диализ. 2017;19(1):22-206.
  2. From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017. Ссылка активна на 20.11.2017. http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/
  3. Болотова Е.В., Дудникова А.В. Хроническая болезнь почек у пациентов с хронической обструктивной болезнью легких: роль частоты обострений. Пульмонология. 2016;25(5):578-83. doi: 10.18093/0869-0189-2016-26-5-578-583
  4. Gaddam S, Gunukula S.K, Lohr J.W, Arora P. Prevalence of chronic kidney disease in patients with chronic obstructive pulmonary disease: a systematic review and meta - analysis. BMC Pulmon Med. 2016;16:158. doi: 10.1186/s12890-016-0315-0
  5. Samoni S, Husain-Syed F, De Rosa S, Ronco C. Cardio-Pulmonary-Renal interactions. Review. G Ital. Nefrol. 2017;34 Suppl 69:162-77.
  6. Chen C-Y, Liao K-M. Chronic Obstructive Pulmonary Disease is associated with risk of Chronic Kidney Disease: A Nationwide Case-Cohort Study. Sci Rep. 2016;6:25855. doi: 10.1038/srep25855
  7. Болотова Е.В., Дудникова А.В. Особенности факторов риска хронической болезни почек у пациентов с хронической обструктивной болезнью легких. Нефрология. 2015;5(19):28-33. https://elibrary.ru/download/ elibrary_24344512_70758187.pdf
  8. Report GOLD: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Ссылка активна на 20.11.2017. http://goldcopd.org/wpcontent/uploads/2016/04/ GOLD_Report_Russian_2014.pdf
  9. Федеральные клинические рекомендации по диагностике и лечению ХОБЛ. Российское респираторное общество. 2016. Ссылка активна на 20.11.2017: http://spulmo.ru/obrazovatelnye-resursy/federalnye-klinicheskie-rekomendatsii/?clear_cache=Y [Federal clinical guidelines for the diagnosis and treatment of COPD. Russian Respiratory Society. 2016. Available from: http://spulmo.ru/obrazovatelnye-resursy/federalnye-klinicheskie-rekomendatsii/?clear_cache=Y (In Russ.)].
  10. Yoshizawa T, Okada K, Furuichi S, Ishiguro T, Yoshizawa A, Akahoshi T, Gon Y, Akashiba T, Hosokawa Y, Hashimoto S. Prevalence of chronic kidney diseases in patients with chronic obstructive pulmonary disease: assessment based on glomerular filtration rate estimated from creatinine and cystatin C levels. Int J Chron Obstruct Pulmon Dis. 2015;10:1283-9. doi: 10.2147/copd.s80673
  11. Болотова Е.В., Дудникова А.В., Являнская В.В. Особенности диагностики хронической болезни почек у больных хронической обструктивной болезнью легких. Клиническая нефрология. 2017;(1):18-22. https://www.nephrologyjournal.ru/ru/archive/article/34433
  12. Нагайцева С.С., Швецов М.Ю., Лукшина Л.П. и др. Впервые выявленная хроническая болезнь почек среди пациентов терапевтического стационара: роль расчета СКФ по методу CKD-EPI. Клиническая медицина. 2015;(7):56-61.
  13. Kim Y.S, Kim H.Y, Ahn H-S, et al. Glomerular filtration rate affects interpretation of pulmonary function test in a Korean general population: results from the Korea National Health and Nutrition Examination Survey 2010 to 2012. Korean J Intern Med. 2016;31(6):1101-9. doi: 10.3904/kjim.2015.148
  14. Ford E.S. Urinary albumin - creatinine ratio, estimated glomerular filtration rate, and all - cause mortality among US adults with obstructive lung function. Chest. 2015;147(1):56-67. doi: 10.1378/chest.13-2482
  15. Ying-Mei Feng, Thijs L, Zhen-Yu Zhang, Wen-Yi Yang, Qi-Fang Huang, Fang-Fei Wei, Kuznetsova T, Jennings A-M, Delles C, Lennox R, Verhamme P, Dominiczak A, Staessen J.A. Glomerular function in relation to circulating adhesion molecules and inflammation markers in a general population. Nephrol Dial Transplant. 2018; 33(3):426-35. doi: 10.1093/ndt/gfx256
  16. Kochi M, Kohagura K, Shiohira Y, Iseki K, Ohya Y. Inflammation as a Risk of Developing Chronic Kidney Disease in Rheumatoid Arthritis. Aguilera A.I, ed. PLoS ONE. 2016;11(8):e0160225. doi: 10.1371/journal.pone.0160225
  17. Barakat M, Mc Donald H, Collier T, et al. Acute kidney injury in stable COPD and at exacerbation. Int J Chron Obstruct Pulm Dis. 2015;10:2067-77. doi: 10.2147/COPD.S88759
  18. Kirkman D.L, Muth B.J, Ramick M.G, Townsend R.R, Edwards D.G. The role of mitochondria derived reactive oxygen species in microvascular dysfunction in chronic kidney disease. Am J Physiol Renal Physiol. Published 8 Nov. 2017;314(3):F423-F429. doi: 10.1152/ajprenal.00321.2017

Copyright (c) 2019 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies